Literature DB >> 2991296

Immortalization of human lymphocytes by co-cultivation with lethally irradiated autologous T-cell lines harbouring human T-cell leukaemia virus-I.

T Akagi, Y Ohtsuki, K Takahashi, I Takeda, T Oka, I Miyoshi.   

Abstract

Human adult peripheral blood lymphocytes were successfully immortalized by co-cultivation with irradiated autologous and homologous T-cell lines harbouring human T-cell leukaemia virus-I (HTLV-I). The efficiency of transformation was the same in both cases. The participation of alloantigen stimulation in co-cultivation procedures is discussed, and it is stressed that factors other than alloantigen stimulation might be required for the efficient immortalization of human T-lymphocytes in vitro by HTLV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991296     DOI: 10.1007/bf00402508

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Functional interactions of viral and histocompatibility antigens at tumor cell surfaces.

Authors:  J W Schrader; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

3.  Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell line carrying type C virus particles.

Authors:  I Miyoshi; S Yoshimoto; I Kubonishi; H Taguchi; Y Shiraishi; Y Ohtsuki; T Akagi
Journal:  Gan       Date:  1981-12

4.  A novel T-cell line derived from adult T-cell leukemia.

Authors:  I Miyoshi; I Kubonishi; M Sumida; S Hiraki; T Tsubota; I Kimura; K Miyamoto; J Sato
Journal:  Gan       Date:  1980-02

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

7.  Cell lines producing human T-cell lymphoma virus show altered HLA expression.

Authors:  D L Mann; M Popovic; P Sarin; C Murray; M S Reitz; D M Strong; B F Haynes; R C Gallo; W A Blattner
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

8.  Detection of H-2Dd and H-2Kd molecules in purified Rauscher leukemia virus.

Authors:  L Schaffar-Deshayes; J Choppin; J P Levy
Journal:  Int J Cancer       Date:  1983-03-15       Impact factor: 7.396

9.  Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

Authors:  H Hoshino; H Esumi; M Miwa; M Shimoyama; K Minato; K Tobinai; M Hirose; S Watanabe; N Inada; K Kinoshita; S Kamihira; M Ichimaru; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Transformation of different phenotypic types of human bone marrow T-lymphocytes by HTLV-1.

Authors:  P D Markham; S Z Salahuddin; B Macchi; M Robert-Guroff; R C Gallo
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

View more
  2 in total

1.  Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures.

Authors:  C D'Onofrio; E Alvino; E Garaci; E Bonmassar; M G Santoro
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

2.  Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.

Authors:  C D'Onofrio; C F Perno; P Mazzetti; G Graziani; R Calio'; E Bonmassar
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.